glp 1 cardiovascular risk 💉 GLP-1's have been FDA approved for over 20 years. 🫀 They have been found to improve overall health and reduce the of cardiovascular disease. 🧬 Obesity is a complex Glucagon-like peptide 1 receptor agonists:

individuals with a prior history of malignancy should seek specialist assessment before considering any GH-stimulating agent, as the decision requires individualised clinical judgement

(10) I.T.Gajger et al (2018) Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera) therapy, to control Nosema ceranae invasions in apiary conditions Journal of Veterinary Pharmacology and Therapeutics, 2018 Aug;41(4):614-621

A challenge for insurers is if an employer comes to them asking for GLP-1 coverage for cosmetic purposes

PlexusDx compounded semaglutide ($189/mo), tirzepatide ($289/mo), and oral options offer accessible GLP-1 access through licensed 503A pharmaciesprovided your provider determines GLP-1 is the right choice for you based on comprehensive evaluation

Immunotherapy in localized microsatellite instability-high/mismatch repair deficient solid tumors: are we ready for a new standard of care